Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 120,885,782
- Total 13F value
- $546,343,961
- Share change
- +1,708,478
- Put/Call ratio
- 177%
- SEC-reported price per share
- $4.53
- Number of holders
- 153
- Value change
- +$6,435,245
- Number of buys
- 73
- Number of sells
- 54
- Shares outstanding
- 334,584,513
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
153
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DCVC Bio, L.P.
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5
13F
Highest disclosed value: $137,295,785
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO has the largest disclosed position value at $137.3M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Disclosed position value
Top 5
DCVC Bio, L.P.
$199.5K
BAILLIE GIFFORD & CO
$137.3M
BAKER BROS. ADVISORS LP
$130.81M
VOYA INVESTMENT MANAGEMENT LLC
$60.66M
Capital World Investors
$47.69M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DCVC Bio, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$199,508
73,892 shares
|
— | 18 Jun 2021 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
denominator unverified
|
$137,295,785
24,044,796 shares
|
— | 31 Dec 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$130,814,690
22,909,753 shares
|
— | 31 Dec 2023 |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$60,664,096
10,624,185 shares
|
— | 31 Dec 2023 |
| Capital World Investors |
13F
Company
|
—
denominator unverified
|
$47,685,883
8,351,293 shares
|
— | 31 Dec 2023 |
| John Hamer |
3/4/5
Director
|
—
denominator unverified
|
$39,783,482
14,734,623 shares
|
— | 31 Aug 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
153
Shares
120,885,782
Rows available
153
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
153
Q1 2024 holders
153
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|